Bergen, Norway 6 December 2022
Lifecare AS will present Q3 2022 financial and operational status in a webcast today, Tuesday 6 December. The webcast will be for all shareholders and interested parties at 13:00 – 14:00 CET.
Lifecare CEO Joacim Holter will participate in the webcast.
There will be a Q&A session following the presentation. The webcast will be available here:
https://teams.microsoft.com/l/meetup-join/19%3ameeting_MjM4ZGE3ZWEtMTNlMC00ZjYzLTljODktNWFjNjVkNjk0Mzcy%40thread.v2/0?context=%7b%22Tid%22%3a%22c5fbb1c6-4eb0-45db-9f3c-6e20ebcd710e%22%2c%22Oid%22%3a%22e067d101-8c82-4495-b6ce-29a800accfd6%22%7d
This is Lifecare:
Lifecare is a Bergen-based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers. Lifecare AS is listed on Euronext Growth (LIFE).
Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40
This stock exchange announcement was published by Joacim Holter, CEO at Lifecare AS, on 6.12.22 at 08:35 CET.